Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase 2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 216NIH 17NETWORK 10OTHER_GOV 6INDUSTRY 4UNKNOWN 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Esophageal Squamous Cell Carcinoma 1Breast Neoplasms 1

Interventions

Radiotherapy, Intensity-Modulated 3Radiotherapy 2Epirubicin 2Cytarabine 2pirarubicin 1durvalumab 1aclacinomycins 1Temozolomide 1Sorafenib 1Radiotherapy, Adjuvant 1Radiation Dose Hypofractionation 1Povidone-Iodine 1Pleurodesis 1Paclitaxel 1Nutrition Assessment 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Methylene Blue 1Indocyanine Green 1Equipment and Supplies 1Drug Therapy 1Doxorubicin 1Docetaxel 1Daunorubicin 1Cyclophosphamide 1Cabergoline 1CAG protocol 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × UNKNOWN × Radiotherapy × Clear all
NCT04851132 2021-06-22

Radiotherapy Plus Durvalumab in Elderly Esophageal Squamous Cell Carcinoma

ChineseAMS

Phase NA Unknown
33 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03320421 2019-01-31

Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery

ChineseAMS

Phase NA Completed
90 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡